GLENMARK PHARMACEUTICALS LTD. | Scrip Code : 532296 | Quarter ending :June 2016 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | Yes | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | No | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 6 | 13,11,52,068 | 13,11,52,068 | 46.48 | 13,11,52,068 | 46.48 | | 46.48 | 13,11,52,068 | - | - | - | (B) Public | 84,904 | 15,10,14,088 | 15,10,14,088 | 53.52 | 15,10,14,088 | 53.52 | | 53.52 | 14,89,47,984 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 84,910 | 28,21,66,156 | 28,21,66,156 | 100.00 | 28,21,66,156 | 100.00 | | 100.00 | 28,01,00,052 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|